What's breaking now, across thousands of outlets.
Novo won't launch its big obesity hope CagriSema in Europe for another “couple of years,” as it will have to conduct new trials at European sites, Novo’s outgoing CFO Karsten Munk Knudsen ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
A new study led by researchers at The University of Hong Kong (HKU) has established the first systematic weekly benchmarks for green space exposure and mental health.
A new study from researchers at Boston Medical Center (BMC) found that Massachusetts neighborhoods given the lowest grades on historic redlining maps had 86% higher annual opioid-related overdose…
Yosemite has closed its cancer-focused second fund at $350 million, a serious jump from January’s first close at $200 million, investor Reed Jobs exclusively told Fortune.
The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue
A specialist team at King Fahd Specialist Hospital in Dammam has successfully removed a rare malignant pelvic tumor from a woman in her thirties using advanced 3D techniques.
Viking aims to enter the weight loss drug market.
